Overview
| Product name | Recombinant Human SLAMF1/CD150 Protein |
|---|
| Catalog No. | RP00510 |
|---|
| Description | Recombinant Human CD150/SLAM Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ala21-Pro237) of human CD150/SLAM (Accession #Q13291) fused with a hFC tag at the C-terminus. |
|---|
| Purity | > 97% by SDS-PAGE. |
|---|
| Endotoxin | < 1 EU/μg of the protein by LAL method. |
|---|
| Formulation | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
|---|
| Species | Human |
|---|
| Calculated MW | 50.25 kDa |
|---|
Background
SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes ofSLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another inwhich protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.
Product information
| Synonym | SLAMF1; CD150; CDw150; SLAM |
|---|
| Expression Host | HEK293 cells |
|---|
| Tag | C-hFC |
|---|
| Swiss-Prot | |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
|---|
| Reconstitution | Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
Y_FC_01.jpg?t=1712649656)
i_FC_01.jpg?t=1702460450)
